These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6408349)

  • 21. The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells.
    Maier T; Levy JG; Kilburn DG
    Cell Immunol; 1980 Dec; 56(2):392-9. PubMed ID: 6451300
    [No Abstract]   [Full Text] [Related]  

  • 22. Natural killer cells and their targets: impact of differentiation on target cell susceptibility.
    Gidlund M; Nilsson K; Tötterman T; Wigzell H
    Haematol Blood Transfus; 1983; 28():466-9. PubMed ID: 6574961
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural cytotoxic cells against solid tumors in mice. IV. Natural cytotoxic (NC) cells are not activated natural killer (NK) cells.
    Lattime EC; Pecoraro G; Stutman O
    Int J Cancer; 1982 Oct; 30(4):471-7. PubMed ID: 7141742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of natural killer cells in the intravascular death of intravenously injected murine tumour cells.
    Bishop CJ; Whiting VA
    Br J Cancer; 1983 Sep; 48(3):441-4. PubMed ID: 6412734
    [No Abstract]   [Full Text] [Related]  

  • 25. Level of activation determines whether inflammatory peritoneal and intratumoral macrophages will promote or suppress in vitro development of cytolytic T lymphocyte activity.
    Gillespie GY; Russell SW
    J Reticuloendothel Soc; 1980 May; 27(5):535-45. PubMed ID: 7373614
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated lysis of murine target cells by nonimmune salmonid lymphoid preparations.
    Hayden BJ; Laux DC
    Dev Comp Immunol; 1985; 9(4):627-39. PubMed ID: 3936734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural cytotoxicity in the mouse embryo. I. Evidence for the presence of natural cytotoxic function in the yolk sac of the 10-day mouse embryo.
    Dahl CA
    J Immunol; 1980 Nov; 125(5):1924-7. PubMed ID: 6776183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells.
    Becker S; Haskill S
    Int J Cancer; 1980 Apr; 25(4):535-41. PubMed ID: 6966262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour cell toxicity for the targets of natural killer cells.
    Fuchs BB; Sterlina AG; Spirande IV; Zedginidze MS; Kogarko YN
    Folia Biol (Praha); 1983; 29(5):358-71. PubMed ID: 6642010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physico-chemical characteristics of tumour cells susceptible to lysis by natural killer (NK) cells.
    Becker S; Stendahl O; Magnusson KE
    Immunol Commun; 1979; 8(1):73-83. PubMed ID: 105988
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the mechanism of lymphocyte-mediated cytolysis. X. Enucleated cells as targets for cytotoxic attack.
    Siliciano RF; Henney CS
    J Immunol; 1978 Jul; 121(1):186-91. PubMed ID: 97346
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytolytic activity of macrophages and T-lymphocytes in regard to tumor cells in the presence of normal tissue cells].
    Lavrovskiĭ VA; Dobrunova EP
    Eksp Onkol; 1990; 12(4):77-8. PubMed ID: 2379495
    [No Abstract]   [Full Text] [Related]  

  • 33. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity.
    Schreiber RD
    Contemp Top Immunobiol; 1984; 13():171-98. PubMed ID: 6428805
    [No Abstract]   [Full Text] [Related]  

  • 35. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 36. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 37. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
    Rees RC; Reynolds CW; Herberman RB
    Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer and other effector cells.
    Stutman O; Lattime EC
    Symp Fundam Cancer Res; 1986; 38():221-58. PubMed ID: 3489260
    [No Abstract]   [Full Text] [Related]  

  • 39. Ability of tumor cells to resist humoral vs. cell-mediated immune attack is controlled by different membrane physical properties.
    Schlager SI
    Biochem Biophys Res Commun; 1982 May; 106(1):58-64. PubMed ID: 6809001
    [No Abstract]   [Full Text] [Related]  

  • 40. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.